Donald S. Coffey

Q: What Schools Are Affiliated With Donald S. Coffey

Donald S. Coffey is affiliated with the following schools: Colorado State University, King University, University of Maryland, College Park, East Tennessee State University, Johns Hopkins University

Donald S. Coffey's AcademicInfluence.com Rankings

Donald S. Coffey

Philosophy

#4745

World Rank

#7371

Historical Rank

#1331

USA Rank

Logic

#2140

World Rank

#3065

Historical Rank

#540

USA Rank

philosophy Degrees

Download Badge

Philosophy

Donald S. Coffey's Degrees

PhD Biochemistry University of Maryland, College Park
Doctorate Medicine University of Maryland, College Park

Why Is Donald S. Coffey Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Donald Straley Coffey was the Catherine Iola and J. Smith Michael distinguished professor of urology at Johns Hopkins University School of Medicine and subsequently professor emeritus. He had a primary appointment in urology and secondary appointments in oncology, pharmacology and pathology.

(See a Problem?)

Donald S. Coffey's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The development of human benign prostatic hyperplasia with age. (1984) (2146)
DNA packaging and organization in mammalian spermatozoa: comparison with somatic cells. (1991) (666)
A fixed site of DNA replication in eucaryotic cells (1980) (612)
Supercoiled loops and eucaryotic DNA replication (1980) (577)
Etiology and disease process of benign prostatic hyperplasia (1989) (558)
Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. (2002) (552)
Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma. (1981) (422)
Telomerase activity: a prevalent marker of malignant human prostate tissue. (1996) (414)
The prostate: An increasing medical problem (1990) (363)
The role of the nuclear matrix in the organization and function of DNA. (1986) (332)
Self-organization, complexity and chaos: The new biology for medicine (1998) (301)
The specific binding of estrogens and androgens to the nuclear matrix of sex hormone responsive tissues. (1980) (277)
Comparison of spontaneous and experimentally induced canine prostatic hyperplasia. (1979) (272)
Cancer as a disease of DNA organization and dynamic cell structure. (1989) (262)
Considerations in the isolation of rat liver nuclear matrix, nuclear envelope, and pore complex lamina. (1981) (249)
Stem cell features of benign and malignant prostate epithelial cells. (1998) (246)
Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. (1998) (242)
A Structural Analysis of the Role of the Nuclear Matrix and DNA Loops in the Organization of the Nucleus and Chromosome (1984) (211)
Clinical and experimental studies of benign prostatic hyperplasia. (1990) (207)
Fourier analysis of cell motility: correlation of motility with metastatic potential. (1989) (196)
Similarities of prostate and breast cancer: Evolution, diet, and estrogens. (2001) (195)
Polymerization of deoxyribonucleotides in relation to androgen-induced prostatic growth. (1968) (194)
Animal models of the hormone-sensitive and -insensitive prostatic adenocarcinomas, Dunning R-3327-H, R-3327-HI, and R-3327-AT. (1978) (191)
Challenges in clinical prostate cancer: role of imaging. (2009) (188)
Genetic instability coupled to clonal selection as a mechanism for tumor progression in the Dunning R-3327 rat prostatic adenocarcinoma system. (1982) (180)
Identification of nuclear matrix proteins in the cancer and normal rat prostate. (1991) (175)
The epidemiology of prostate cancer in Jamaica. (1998) (170)
Gleason score 6 adenocarcinoma: should it be labeled as cancer? (2012) (169)
Nuclear matrix protein patterns in human benign prostatic hyperplasia and prostate cancer. (1993) (165)
Newly replicated DNA is associated with DNA topoisomerase II in cultured rat prostatic adenocarcinoma cells (1986) (164)
Nuclear structure and the three‐dimensional organization of DNA (1991) (159)
The role of androgens and estrogens in the pathogenesis of experimental nonbacterial prostatitis. (1988) (158)
A new method to assess metastatic potential of human prostate cancer: relative nuclear roundness. (1982) (149)
The tissue matrix: cell dynamics and hormone action. (1990) (146)
Characterization of the Dunning R3327H prostatic adenocarcinoma: an appropriate animal model for prostatic cancer. (1977) (142)
Prostate cancer. An overview of an increasing dilemma (1993) (142)
Correlation of nuclear morphometry with progression of breast cancer (1991) (139)
Cell structure and DNA organization. (1991) (134)
Synergistic enhancement by tumor necrosis factor of in vitro cytotoxicity from chemotherapeutic drugs targeted at DNA topoisomerase II. (1987) (132)
Spontaneous benign prostatic hyperplasia in the beagle. Age-associated changes in serum hormone levels, and the morphology and secretory function of the canine prostate. (1983) (129)
New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia. (1999) (127)
Development of canine benign prostatic hyperplasia with age (1986) (123)
The differential effects of neonatal androgen, estrogen and progesterone on adult rat prostate growth. (1986) (121)
Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease‐free survival among patients with prostate cancer (1992) (120)
Computerized image analysis of nuclear shape as a prognostic factor for prostatic cancer (1982) (118)
Sex steroid imprinting of the immature prostate. Long-term effects. (1978) (114)
Biological properties of the nuclear matrix: steroid hormone binding. (1982) (110)
Soy of dietary source plays a preventive role against the pathogenesis of prostatitis in rats (1992) (107)
Bacterial survival strategies suggest rethinking cancer cooperativity. (2012) (101)
Tissue specificity of the hormonal response in sex accessory tissues is associated with nuclear matrix protein patterns. (1990) (99)
Changes in dihydrotestosterone metabolism associated with the development of canine benign prostatic hyperplasia. (1981) (99)
Nuclear‐Cytoskeletal interactions: Evidence for physical connections between the nucleus and cell periphery and their alteration by transformation (1992) (97)
Human androgen receptor binding to the androgen response element of prostate specific antigen. (1994) (95)
The relationship of the nuclear matrix to cellular structure and function. (1978) (95)
The Cancer Diaspora: Metastasis beyond the Seed and Soil Hypothesis (2013) (92)
A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis. (1989) (91)
Telomerase: a promising marker of biological immortality of germ, stem, and cancer cells. A review. (1997) (91)
Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cells (1994) (90)
Hyperthermic biology and cancer therapies: a hypothesis for the "Lance Armstrong effect". (2006) (90)
Early cell motility changes associated with an increase in metastatic ability in rat prostatic cancer cells transfected with the v-Harvey-ras oncogene. (1988) (86)
Effects of neonatal steroids on male sex tissues. (1979) (85)
Tumor cell heterogeneity : origins and implications (1982) (81)
The characterization of a newly identified, highly metastatic variety of Dunning R 3327 rat prostatic adenocarcinoma system: the MAT LyLu tumor. (1981) (81)
STRUCTURAL ALTERATION IN ISOLATED RAT LIVER NUCLEI AFTER REMOVAL OF TEMPLATE RESTRICTION BY POLYANIONS (1972) (78)
Association of glyceraldehyde-3-phosphate dehydrogenase expression with cell motility and metastatic potential of rat prostatic adenocarcinoma. (1993) (77)
Control of prostate growth. (1981) (76)
The effects of basic fibroblast growth factor and suramin on cell motility and growth of rat prostate cancer cells. (1991) (76)
Concepts related to salt resistant estradiol receptors in rat uterine nuclei: nuclear matrix. (1977) (73)
DNA loop domains in mammalian spermatozoa (1989) (72)
Telomerase is activated in the prostate and seminal vesicles of the castrated rat. (1996) (71)
Cellular harmonic information transfer through a tissue tensegrity-matrix system. (1991) (70)
The application of perpendicular and forward light scatter to assess nuclear and cellular morphology. (1984) (70)
Specific organization of genes in relation to the sperm nuclear matrix. (1990) (70)
The interaction of natural and synthetic polyanions with mammalian nucleo. I. DNA synthesis. (1970) (70)
Identification of a sperm nuclear annulus: a sperm DNA anchor. (1989) (69)
The interaction of natural and synthetic polyanions with mammalian nucleo. II. Nuclear swelling. (1970) (69)
Growth-related elevations of DNA topoisomerase II levels found in Dunning R3327 rat prostatic adenocarcinomas. (1987) (68)
Metastatic potential prediction by a visual grading system of cell motility: prospective validation in the Dunning R-3327 prostatic adenocarcinoma model. (1988) (65)
Biochemical characterization of prostatic nuclei. I. Androgen-induced changes in nuclear proteins. (1971) (65)
High mobility group protein I(Y): a candidate architectural protein for chromosomal rearrangements in prostate cancer cells. (2002) (63)
Prostate tumor biology and cell kinetics--theory. (1981) (62)
Prostate-Specific Antigen Doubling Time as a Surrogate Marker for Evaluation of Oncologic Drugs to Treat Prostate Cancer (2004) (60)
Ability to predict biochemical progression using Gleason score and a computer-generated quantitative nuclear grade derived from cancer cell nuclei. (1996) (58)
Quantitative determination of prostatic epithelial and stromal hyperplasia by a new technique. Biomorphometrics. (1978) (57)
Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. I. Testing of a digitization system. (1988) (57)
Prediction of metastatic potential by a new grading system of cell motility: validation in the Dunning R-3327 prostatic adenocarcinoma model. (1987) (57)
A novel M(r) 32,000 nuclear phosphoprotein is selectively expressed in cells competent for self-renewal. (1993) (57)
Biomarkers, Surrogate End Points, and the Acceleration of Drug Development for Cancer Prevention and Treatment (2004) (57)
The predominant protein of canine seminal plasma is an enzyme. (1984) (55)
Nuclear roundness factor measurement for assessment of prognosis of patients with prostatic carcinoma. II. Standardization of methodology for histologic sections. (1988) (55)
Prostate Cancer: The Magnitude of the Problem in the United States (1988) (55)
Tumor necrosis factor enhances the in vitro and in vivo efficacy of chemotherapeutic drugs targeted at DNA topoisomerase II in the treatment of murine bladder cancer. (1987) (51)
Biochemical characterization of prostatic nuclei. II. Relationship between DNA synthesis and protein synthesis. (1971) (51)
New concepts in studying the control of normal and cancer growth of the prostate. (1987) (51)
High mobility group protein HMGI(Y) enhances tumor cell growth, invasion, and matrix metalloproteinase‐2 expression in prostate cancer cells (2004) (50)
Quantitative nuclear morphometry, Markovian texture descriptors, and DNA content captured on a CAS-200 Image analysis system, combined with PCNA and HER-2/neu immunohistochemistry for prediction of prostate cancer progression. (1994) (50)
Future prospects in prostate cancer (1999) (48)
Niche Inheritance: A Cooperative Pathway to Enhance Cancer Cell Fitness Through Ecosystem Engineering (2014) (46)
Flutamide. Mechanism of action of a new nonsteroidal antiandrogen. (1976) (46)
Time lapse videomicroscopic identification of Dunning R-3327 adenocarcinoma and normal rat prostate cells. (1987) (46)
Familial study of prostate cancer in Jamaica. (1998) (46)
Characterization of the subtypes of cell motility in ageing human skin fibroblasts (1990) (45)
Effect of age, castration, and testosterone replacement on the development and restoration of canine benign prostatic hyperplasia (1987) (45)
Experimental models for the study of prostatic adenocarcinoma. (1977) (45)
There are multiple forms of glyceraldehyde‐3‐phosphate dehydrogenase in prostate cancer cells and normal prostate tissue (1996) (43)
The regulation of nuclear DNA template restrictions by acidic polymers. (1974) (43)
Prediction of prognosis in untreated stage A2 prostatic carcinoma (1992) (42)
Sperm granulomas: an adverse effect of vasectomy. (1973) (41)
Effects of aging on prostate growth in beagles. (1986) (41)
A new model for studying the effect of drugs on prostatic growth. 1. Antiandrogens and DNA synthesis. (1973) (40)
Aromatase inhibition in the dog. I. Effect on serum LH, serum testosterone concentrations, testicular secretions and spermatogenesis. (1988) (40)
Characterization of two new enzymatic activities of the rat ventral prostate: 5α-Androstane-3β, 17β-diol 6α-Hydroxylase and 5α-androstane-3β,17β-Diol 7α-Hydroxylase (1979) (39)
The identification and characterization of a new c1903 steroid metabolite in the eat ventral prostate: 5α-androstane-3β, 6α, 17β-triol (1979) (39)
Development of androgen resistance in prostatic cancer. (1987) (39)
Preneoplastic alterations in nuclear morphology that accompany loss of tumor suppressor phenotype. (1991) (39)
Phosphorylation of nuclear matrix proteins in isolated regenerating rat liver nuclei. (1977) (38)
Chaotic oscillations in cultured cells: rat prostate cancer. (1996) (38)
The adverse effects of sperm during vasovasostomy. (1977) (37)
Models for development of nonreceptor methods for distinguishing androgen-sensitive and -insensitive prostatic tumors. (1979) (36)
Sterility in male animals induced by injection of chemical agents into the vas deferens. (1973) (36)
The relationship of cellular structure and function: the matrix system. (1981) (36)
The use of multiparameter flow cytometry to assess tumor cell heterogeneity and grade prostate cancer (1984) (35)
Understanding the Cancer Biology Universe: Enigmas, Context and Future Prospects (2002) (35)
A critical review of the concept of total androgen ablation in the treatment of prostate cancer. (1987) (35)
Light-microscopic stereologic analysis of spontaneous and steroid-induced canine prostatic hyperplasia. (1987) (35)
A Multidisciplinary Analysis of Controversies in the Management of Prostate Cancer (1988) (35)
Cell surface charge in predicting metastatic potential of aspirated cells from the Dunning rat prostatic adenocarcinoma model. (1988) (33)
Concepts in prostatic cancer biology: Dunning R-3327 H, HI, and AT tumors. (1980) (33)
Aromatase inhibition in the dog. II. Effect on growth, function, and pathology of the prostate. (1988) (31)
The effect of extracellular matrix interactions on morphologic transformation in vitro. (1991) (30)
Prediction of metastatic potential in an animal model of prostate cancer: flow cytometric quantification of cell surface charge. (1989) (30)
Preliminary immunohistochemical characterization of a monoclonal antibody (PRO:4-216) prepared from human prostate cancer nuclear matrix proteins. (1997) (29)
Release of Nuclear DNA Template Restrictions by Specific Polyribonucleotides (1971) (29)
Modifications of the intermediate filament and nuclear matrix networks by the extracellular matrix. (1991) (28)
Controversies in the management of lower urinary tract symptoms: an overview. (1998) (28)
Cell motility as a chemotherapeutic target. (1991) (27)
Nuclear matrix localization of high mobility group protein I(Y) in a transgenic mouse model for prostate cancer (2003) (26)
Chapter 12 – The Effects of Androgens on DNA and RNA Synthesis in Sex Accessory Tissue (1974) (26)
The requirement of the testis in establishing the sensitivity of the canine prostate to develop benign prostatic hyperplasia. (1994) (26)
Determination of canine prostatic size in situ: Comparison of direct caliper measurement with radiologic and transrectal ultrasonographic measurements (1989) (25)
Nuclear matrix proteins as proteomic markers of preneoplastic and cancer lesions : commentary re: G. Brunagel et al., nuclear matrix protein alterations associated with colon cancer metastasis to the liver. Clin. Cancer Res., 8: 3039-3045, 2002. (2002) (24)
Androgen glucuronides I. Direct formation in rat accessory sex organs (1977) (24)
Effect of pentosan, a novel cancer chemotherapeutic agent, on prostate cancer cell growth and motility (1992) (23)
3D Shape Modeling for Cell Nuclear Morphological Analysis and Classification (2018) (23)
The management of clinically localized prostate cancer. (1987) (22)
3D Cell Nuclear Morphology: Microscopy Imaging Dataset And Voxel-Based Morphometry Classification Results (2017) (22)
Characterization of nuclear morphology and nuclear matrices in ageing human fibroblasts (1992) (21)
Immunologic implications of vasectomy. II. Serum-mediated immunity. (1974) (21)
Nonsurgical treatment of human benign prostatic hyperplasia. (1975) (21)
Relationship of seminal volume to size and disease of the prostate in the beagle. (1979) (20)
Effects of extracellular matrix components and dihydrotestosterone on the structure and function of human prostate cancer cells (1992) (20)
New model for studying the effects of cancer chemotherapeutic agents on the growth of the prostate gland (1975) (20)
Immunologic implications of vasectomy. I. Cell-mediated immunity. (1974) (19)
Requirements for an idealized animal model of prostatic cancer. (1980) (19)
Symmetry and symmetry breaking in cancer: a foundational approach to the cancer problem (2017) (18)
Size requirement of polyinosinic acid for DNA synthesis, viral resistance, and increased survival of leukaemic mice. (1972) (18)
Differences in the effects of estradiol on dihydrotestosterone induced prostatic growth of the castrate dog and rat. (1981) (17)
Organ site specificity for cancer in chromosomal instability disorders. (1982) (17)
Prostate cancer metastasis: Talking the walk (1996) (17)
New insights and methodologies are needed to solve the many epidemiologic enigmas of prostate cancer. (2001) (17)
Release of chromatin template restriction in rabbit spermatozoa. (1975) (16)
Cell kinetic studies of prostatic cancer: adjuvant therapy in animal models. (1977) (16)
Methods for monitoring canine prostate size: Internal and external caliper measurements (1985) (16)
Influence of age, strain, and the testes on rat prostate hormone sensitivity (1991) (16)
Hormone Receptors and the Nuclear Matrix (1983) (16)
The release of chromatin template restrictions by natural polyribonucleotides. (1971) (16)
Identification and Characterization of Nuclease-stabilized RNA Molecules That Bind Human Prostate Cancer Cells via the Prostate-specific Membrane Antigen 1 (2002) (15)
CHAPTER 2 – The Role of the Nuclear Matrix in Steroid Hormone Action (1983) (15)
The dog prostate under defined hormonal influences: an approach to experimental induced prostatic growth. (1980) (15)
Androgen glucuronide. II. DIfferences in its formation by human normal and benign hyperplastic prostates. (1978) (14)
Effects of polyinosinic acid and polycytidylic acid on the deoxyribonucleic acid template activity of isolated nuclei and soluble chromatin from rat liver. (1972) (14)
Animal models in the study of prostatic cancer (1979) (14)
Correlation of prognosis to nuclear roundness and to flow cytometric light scatter. (1987) (14)
Male sterility induced by ethanol injection into the vas deferens. (1973) (14)
Benign and malignant prostatic neoplasms: human studies. (1994) (13)
Training the urologic scientist---an endangered species. (2002) (13)
The identification and characterization of the c19o3 steroid metabolites of 5α-androstane-3β, 17β-diol produced by the canine prostate: 5α-androstane-3β, 6α, 17β-triol and 5α-androstane-3β, 7α, 17β-triol (1980) (13)
Frontiers in prostate cancer. Telomeres and chaos (1995) (13)
Effects of testosterone on adenosine triphosphate and nicotinamide adenine dinucleotide levels, and on nicotinamide mononucleotide adenylytransfersee activity, in the ventral prostate of castrated rats. (1968) (11)
A comparison of the hormone responsiveness of the prostate and seminal vesicles. (1974) (11)
The specific binding of estradiol to the nuclear matrix. (1979) (11)
Androgen-induced changes in the DNA polymerase activity of coagulating glands of castrated rats. (1968) (10)
Differential effects of estrogen treatment on canine seminal plasma components. (1980) (10)
The Tissue Matrix and The Regulation of Gene Expression in Cancer Cells (1993) (9)
Cell motility as an index of metastatic ability in prostate cancers: results with an animal model and with human cancer cells. (1992) (9)
Growth characteristics and immunogenicity of the R-3327 rat prostate carcinoma. (1978) (9)
The Temporal Requirements for Androgens During the Cell Cycle of the Prostate Gland (1972) (9)
Differences in the mechanism of action of medrogestone and cyproterone acetate. (1975) (9)
The effects of immunosuppression on sperm granulomas in vasectomized rats. (1974) (9)
Characterization of two new enzymatic activities of the rat ventral prostate: 5 alpha-androstane-3 beta, 17 beta-diol 6 alpha-hydroxylase and 5 alpha-androstane-3 beta, 17 beta-diol 7 alpha-hydroxylase. (1979) (9)
The effects of amphotericin B on prostatic and testicular function in the dog. (1969) (8)
Structural aspects of mammalian DNA replication: topoisomerase II. (1987) (8)
Hormonal Therapy of Prostate Cancer: Limitations in the Total Androgen Ablation Concept (1988) (7)
Changing the energy habitat of the cancer cell in order to impact therapeutic resistance. (2011) (7)
Release of DNA template restrictions in rabbit spermatozoa and rat liver nuclei. (1976) (7)
The concept of evolution in the pathogenesis and treatment of prostate cancer. (1997) (6)
The biology of prostate cancer: new and future directions in predicting tumor behavior. (1992) (6)
New biochemical methods to determine androgen sensitivity of prostatic cancer: the relative enzymatic index (REI). (1979) (6)
Recombinant human tumor necrosis factor enhances radiosensitivity and improves animal survival in murine neuroblastoma. (1992) (6)
A new method for suppressing sperm granuloma formation in the vasectomized rat. (1974) (5)
The Biology Behind Nuclear Matrix Proteins as Proteomic Markers of Preneoplastic and Cancer Lesions (2002) (5)
Effects of hormones in the newborn period on the development of the penis. (1977) (5)
The effect of radiation on prostatic growth. (1976) (5)
Effect of different sizes of polyacrylic acid on the structure and DNA template properties of isolated rat liver nuclei and soluble chromatin (1973) (4)
Effect of Inhibiting Endogenous Estradiol Production on Androgen Secretion by Dog Testes Perfused in Vitro a (1987) (4)
Concepts and limitations in the application of radiolabeled antiandrogens, estrogens, or androgens as isotopic scanning agents for the prostate. (1975) (4)
Molecular and Cellular Biology of Prostate Cancer (2012) (4)
Evolution: Back to the future to understand and control prostate cancer (2014) (3)
Tissue Specificity and Cell Death are Associated with Specific Alterations in Nuclear Matrix Proteins (1991) (3)
DNA Organization in the Interphase Nucleus and Metaphase Chromosome (1990) (3)
Specificity of cell membrane antigens in prostatic cancer. (1975) (3)
Perspectives in Cancer Research Cancer as a Disease of DNA Organization and Dynamic Cell Structure1 (1989) (3)
Cell Motility and Structural Harmonics in Prostate Cancer (1991) (3)
The identification and characterization of a new C19O3 steroid metabolite in the rat ventral prostate: 5 alpha-androstane-3 beta, 6 alpha, 17 beta-triol. (1979) (3)
Reply to “Chaos in cancer?” (1998) (3)
Prediction of Metastatic Potential by a New Grading System of Cell Motility: Validation in the Dunning R-3327 Rat Prostatic Adenocarcinoma Model and Preliminary Application to Human Urological Cancer (1987) (2)
The identification and characterization of the C19O3 steroid metabolites of 5 alpha-androstane-3 beta,17 beta-diol produced by the canine prostate: 5 alpha-androstane-3 beta,6 alpha,17 beta-triol and 5 alpha-androstane-3 beta,7 alpha,17 beta-triol. (1980) (2)
Do bone marrow endothelial cells have specific house numbers, and how is this involved in metastasis? (1998) (2)
Specificity of cell membrane antigens in prostate cancer. (1978) (2)
New approaches to the evaluation of the metastatic ability of renal cancer and new approaches to chemotherapy. (1990) (2)
Chemical induction of male sterility by injection of vasosclerosing agents (1973) (2)
Correlation of molecular size requirements of poly i poly c in increasing the survival of mice with l1210, inducing interferon like substances in vivo and in vitro, and releasing nuclear dna template restrictions. Abstr. (1972) (2)
Serum-mediated immunoresponses to spermatozoa. (1975) (2)
The Nuclear Matrix: an Organizing Structure for the Interphase Nucleus and Chromosome (1985) (2)
Publisher Correction: 3D Shape Modeling for Cell Nuclear Morphological Analysis and Classification (2018) (2)
Grading Prostate Cancer (1988) (1)
New concepts and controversies concerning prostate cancer. (1984) (1)
New concept in the control of abnormal prostatic growth: combination hormone therapy (1974) (1)
Current concepts and approaches to the study of prostate cancer : proceedings of a meeting held in Prouts Neck, Maine, October 18-20, 1985 (1987) (1)
Studies on Crystalline D-Amino Acid Oxidase SYNTHESIS OF e-iV-(I-CARBOXYETHYL)-L-LYSINE* (2003) (1)
The Effects of Aromatase Inhibition on the Growth, Function and Pathology of the Canine Prostate (1987) (1)
A pioneer in developing animal models for prostate cancer (2000) (1)
Excerpts of Minutes of Prostate Cancer Working Group Committee Meeting on Diagnostic Nomenclature, February 11, 1987, Cross Keys Inn, Baltimore, Maryland (1988) (1)
Effect of aromatase inhibition on prostatic growth and pathology, prostatic and serum androgen concentrations, and testicular androgen secretion in beagles[Poster 29] (1987) (0)
Frontiers in Urology for the New Millennium (2000) (0)
3D Shape Modeling for Cell Nuclear Morphological Analysis and Classification (2018) (0)
The effects of 5-fluorouracil on prostatic DNA synthesis. (1975) (0)
Future developments and new research in genitourinary cancers. Perspectives (1987) (0)
Tumor-specific immunity in patients with prostatic adenocarcinoma or benign prostatic hyperplasia. (1977) (0)
Abstract 411: Chromatin regulatory nuclear proteins and nuclear architecture in cell lines derived from curable and incurable metastatic human cancers. (2013) (0)
Immunologic implication of vasectomy: 1. cell-mediated immunity. (1974) (0)
Chapter 1 – The Molecular and Cellular Biology of Urologic Cancers (2005) (0)
Summations, Perspectives and Future Needs (1988) (0)
Contents, Vol. 18, 1968 (1968) (0)
Gerald P. Murphy 1934–2000 (2000) (0)
Current concepts in the study of bladder cancer. (1978) (0)
High Mobility Group Protein I(Y): A Candidate Architectural Protein for Chromosomal Rearrangements in Prostate Cancer Cells 1 (2002) (0)
Panel Discussion: Management of Stages B1 and B2 Disease (1988) (0)
WITHDRAWN: Evolution: Back to the future to understand and control prostate cancer (2014) (0)
Special properties of 5α androstane 3β, 17β diol on the growth of the sex accessory tissues (1978) (0)
Fitness of antibiotic-resistant microorganisms and compensatory mutations (1998) (0)
Prostate cancer research: current concepts and controversies. (1983) (0)
Proc. V Int. Congr. Endocrinology, Vol. II: Current concepts (1977) (0)
Estrogens: A Hidden Factor and New Target in Preventing Abnormal Growth of the Prostate. (2005) (0)
Abstract 1139: Extracellular matrix components direct chromatin texture and nuclear morphological changes in epithelial-mesenchymal transition (2014) (0)
SP-3 New frontiers in Urology (2004) (0)
Foreword (2001) (0)
INFLAMMATORY REGENERATIVE ATROPHY (IRA) OF THE PROSTATE (1999) (0)
Dedication of this issue to: William Wallace Scott, MD, PhD, DSc. (2004) (0)
81 Mechanisms for hormone insensitivity and tumor cell heterogeneity (1983) (0)
Aptamer Adaptability: Utilizing Tumor Cell Surface Heterogeneity to Self-Select Appropriate Diagnostic and Therapeutic Agents (1997) (0)
DNA synthesis: a model for studying the effects of cancer chemotherapeutic agents on androgen induced growth of the prostate (1975) (0)
The effects of amphotericin B on prostatic and testicular function in the dog. (1969) (0)
PD21-06 FLUID DYNAMICS AND MORPHOLOGY IN THE OBSTRUCTED URETHRA (2018) (0)

This paper list is powered by the following services:

Other Resources About Donald S. Coffey

en.wikipedia.org

What Schools Are Affiliated With Donald S. Coffey?

Donald S. Coffey is affiliated with the following schools:

Donald S. Coffey's Academic­Influence.com Rankings